The Supreme Court rejects a request from Johnson & Johnson (JNJ -0.1%) to reinstate a $1.67B...

|By:, SA News Editor

The Supreme Court rejects a request from Johnson & Johnson (JNJ -0.1%) to reinstate a $1.67B court ruling against Abbott Laboratories (ABT -0.4%) in a patent infringement case related to its Humira treatment for arthritis that contributes close to 20% of ABT's annual revenue.